Analysis and management of drug related problems on a nephrology ward from a pharmacist's point of view

Autoři

DVORACKOVA E. RYCHLÍČKOVÁ Jitka PAVEK P. HOJNY M. VLCEK J.

Rok publikování 2019
Druh Článek v odborném periodiku
Časopis / Zdroj Pharmazie
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
www https://www.ingentaconnect.com/contentone/govi/pharmaz/2019/00000074/00000010/art00011?crawler=true&mimetype=application/pdf
Doi http://dx.doi.org/10.1691/ph.2019.9568
Klíčová slova CHRONIC KIDNEY-DISEASE; CLINICAL PHARMACISTS; OUTCOMES; CARE; INTERVENTIONS; MEDICATIONS; PREVALENCE; GUIDELINE; SERVICES; IMPACT
Popis The main goal of the study was to determine the incidence and the character of drug related problems (DRPs) identified in chronic kidney disease patients by the clinical pharmacist at the nephrology department. As secondary objective, the aim was to identify the frequency and character of DRPs of selected high risk drugs in medication reviews. The clinical pharmacist reviewed patients. medication records and made drug therapy-related recommendations to physicians. The clinical pharmacists. interventions were categorized using an adaptation of the Pharmaceutical Care Network Europe. During the study period (January 2016 - June 2018) the clinical pharmacist performed 1192 interventions in 1870 adult patients admitted to the Nephrology Department. The most frequent DRP was untreated indication 324 (27.18%) of all interventions, and incorrect dose 248 (20.81%). Anti-infectives were identified as the drug category with the highest frequency of interventions. Almost 93% of all interventions were accepted by the attending physicians. Still within the second objectives, underdosing was observed as the most frequent problem for renally excreted drugs. It was found that an incorrect dose is a very frequent issue at the nephrology department. Surprisingly, the main problem was underdosing. In the category of renally excreted drugs, underdosing was observed in antithrombotics and antivirals. The above- mentioned results prove the need of a clinical pharmacist, preferably in sense of maximizing of the treatment effect and improving the care of patients.

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info